Results 131 to 140 of about 95,577 (390)
The Physiology and Psychology of Exercise and Parkinson\u27s Disease [PDF]
, 2015 Parkinson’s disease is one of the most common degenerative neurological disorders and is currently lacking a cure. While physicians have long debated over the best treatment for Parkinson’s symptoms, treatments such as oral medication and deep brain ...
Gibson, Jess
core +1 more source
Alexithymia and apathy in Parkinson's disease: neurocognitive correlates [PDF]
, 2013 Non-motor symptoms such as neuropsychiatric and cognitive dysfunction have been found to be common in Parkinson’s disease (PD) but the relation between such symptoms is poorly understood.
Bogdanova, Yelena, Cronin-Golomb, A.
core +2 more sources
Drug Design, Development and Therapy, 2012 Xinxin Yang,1,* Yinghui Chen,2,* Xiaoyun Hong,3 Na Wu,1 Lu Song,1 Weien Yuan,3 Zhenguo Liu11Department of Neurology, Xinhua Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China; 2Department of Neurology, Jinshan ...
Song L,Yuan W +5 more
doaj
Communications BiologyParkinson’s disease is managed using levodopa; however, as Parkinson’s disease progresses, patients require increased doses of levodopa, which can cause undesirable side effects. Additionally, the oral bioavailability of levodopa decreases in Parkinson’s
Gang Cheng +4 more
doaj +1 more source
Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa–Levodopa
Clinical Pharmacokinetics, 2017 Parkinson’s disease (PD) is a chronic progressive neurological disorder characterized by resting tremor, rigidity, bradykinesia, gait disturbance, and postural instability. Levodopa, the precursor to dopamine, coadministered with carbidopa or benserazide,
A. Mittur, Suneel K. Gupta, N. Modi
semanticscholar +1 more source
Differential diagnostic relevance of high resolution magnetic resonance in patients with possible multiple system atrophy (MSA) – a case report [Važnost uporabe magnetne rezonancije visoke rezolucije u dijagnostici moguće multiple sistemske atrofije - prikaz slučaja] [PDF]
, 2011 Multiple system atrophy (MSA) is sporadic, progressive neurodegenerative disorder characterized clinically by autonomic dysfunction, Parkinsonism (MSA-P), and cerebellar ataxia (MSA-C) in any combination.
Bačić Baronica, Koraljka +3 more
core
Movement Disorders Clinical Practice, EarlyView.Abstract Background Dysphagia significantly impacts prognosis in individuals with multiple system atrophy (MSA). While video‐based assessments are practical, their limited availability highlights the need for a simple tool such as the Dysphagia Severity Scale (DSS) in clinical practice.
Ryunosuke Nagao +8 more
wiley +1 more source
Sodium valproate in the treatment of levodopa-induced dyskinesia. [PDF]
, 1978 Paul A. Price +2 more
openalex +1 more source
Clinical Parkinsonism & Related Disorders, 2023 Introduction: Motor complications (MCs) compromise therapy in many patients suffering from Parkinson’s Disease. By achieving more physiologic stimulation of dopamine-receptors, the continuous dopamine stimulation hypothesis suggests that longer-acting ...
Christian Ineichen +3 more
doaj